Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(20 sites)
United States
Valkyrie Clinical Trials, Los Angeles, California UCLA, Los Angeles, California UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center), San Francisco, California University of Colorado - Anschutz Cancer Pavilion, Aurora, Colorado Yale Cancer Center, New Haven, Connecticut